Best Initiative Awards 2018 Awarded Best Product by Correo Farmacéutico.

  • Aboca’s integrated research and development rewarded again in Spain.
  • In the year of its 40th Anniversary, the company wins recognition for its latest strategic launch.

April 2018 - Aboca, a company that, when it comes to developing new products, carries out integrated research in a systematic way and with a constant desire for improvement, has once again been awarded for one of its strategic launches.

Once again, the judges of the prestigious Best Initiative Awards, which this year celebrated its XVI edition, a demonstration of its consolidation in the sector, chose an Aboca product, COLILEN IBS, as an innovation worthy of recognition.

Aboca has taken the award in the Spanish capital of  Madrid in the magnificent setting of the Teatros del Canal, the perfect setting for a gala held on March 9th and which also this year brought together over 600 people: from eminent public and private health authorities to the most influential members of the pharmaceutical industry and health sector, everyone wanted to attend and share this moment that ever since the beginning has been an unmissable event.

Aboca is once again thankful for this recognition of the work it does every day, and it will act as one more motivation to keep working and researching into the plant-based molecular complexes that make up its product range dedicated to improving health.

Aboca’s integrated research and development rewarded again in Spain. In the year of its 40th Anniversary, the...
Saturday, 18 November in Asti, during the 14th edition of the “Premio del Gruppo del Gusto” (the Gastronomy Group Prize...
Aboca's participation in Expopharm 2017 has a dual purpose: to introduce the most recent breakthroughs in products...